Home
The Academy
Articles
White Papers
Interviews
Podcasts
Webinars
Enroll for Updates
Contact
Pharma IQ
[] Generating Metabolically Active Hepatocytes from Pluripotent Stem Cells
Week 1 --Reducing late stage attrition and early safety assessments and mitigation
Pre-Clinical Toxicity: Avoiding Common Mistakes in Early Development
Reducing Late-Stage Biologic Failure with Immune Assays- An Interview with Harald Kropshofer
Week 2 -- Improving Predictability Methods
3 Reasons Why an Early Toxicity Assessment Strategy is Important
Week 3 -- Improving Usability of Cellular
Cultures
Generating Metabolically Active Hepatocytes from Pluripotent Stem Cells
Home
The Academy
Articles
White Papers
Interviews
Podcasts
Webinars
Enroll for Updates
Contact
Pharma IQ